0B68 Bhatia, Avnish - Thomas Jefferson University - Thomas Jefferson University
Dr. Bhatia

Avnish Bhatia, MD

Contact Dr. Bhatia

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 923-5676

Most Recent Peer-reviewed Publications

  1. Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome
  2. HHV-8-associated multicentric castleman's disease in HIV negative patient: A novel therapy for an orphan disease
  3. Rituximab in autoimmune pancytopenia: A case report and review of literature
  4. A second case of myelodysplastic syndrome with t(9;12)(q22;p12) [1]
  5. Aberrant blood grouping results in a patient with splenomegaly and thrombocytopenia
  6. Case report of an unusually prolonged complete remission with fludarabine and cyclophosphamide followed by rituximab in refractory, previously treated, chronic lymphocytic leukemia
  7. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)
  8. Metastasis of an esophageal carcinoma to the soft tissue in the elbow
  9. MYeloblast cells derived from MDS patient with capacity for continuous growth in vitr 0B68 o, autocrine GM-CSF production and resistance to FAS-induced apoptosis
  10. Topotecan, fludarabine, aRA-C and G-CSF (T-FLAG) for aggressive myelodysplastic syndromes and acute myelogenous leukemia in the elderly: A dose finding for topotecan study
  11. Treatment of primary defective iron-reutilization syndrome: Revisited
  12. Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation
  13. A pilot trial of 13-cis-retinoic acid and alpha-tocopherol with recombinant human erythropoietin in myelodysplastic syndrome patients with progressive or transfusion-dependent anemias
  14. Is minimal residual disease in the peripheral-blood stem-cell transplantation of chronic myelogenous leukemia important? [2]
  15. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM)
  16. Clinical heterogeneity reflects biologic diversity in chronic lymphocytic leukemia
  17. Interactive computer-based programs for a cancer learning center
  18. Richter's syndrome associated with loss of response to transforming growth factor-beta
  19. Anti-Baka neonatal alloimmune thrombocytopenia: Possible prevention by intravenous immunoglobulin
  20. Hematologic effects of androgens revisited: An alternative therapy in various hematologic conditions